Monitoring: Cardiovascular: Heart rate (at regular intervals during Wegovy therapy) Gastrointestinal: For signs/symptoms of acute pancreatitis (after starting this drug) Metabolic: Blood glucose in patients with diabetes mellitus (before starting and during Wegovy therapy) Ocular: For progression of diabetic retinopathy in patients with history of diabetic retinopathy Renal: Renal function in patients with adverse reactions that could lead to volume depletion (during therapy, especially during initiation and escalation) Patient advice: Read the US FDA-approved patient labeling (Medication Guide and Instructions for Use, as applicable)
The ACR (American College of Rheumatology) 20% improvement index response was observed in 39% of the RA-1 group versus 30% of placebo
Warrilow A, Turner M, Naumovski N, Somerset S (2023) Role of cholecystokinin in satiation: a systematic review and meta-analysis
This is another form of glutathione where an "acetyl group" is attached to the molecule to help it stay stable
Given cryo-EM structures of the GLP-1R in complex with G s are stabilised by trapping the nucleotide-free G protein on the ligand-activated receptor, it is not surprising that the G s interactions are similar across the four structures, even when bound by different agonists, nonetheless, the MD simulations revealed potential differences in the dynamics of these interactions
